Status:
UNKNOWN
Prevalence and Risk Factors for Coxiella Burnetii Seropositivity (Q Fever) Among Adults in Western France
Lead Sponsor:
Nantes University Hospital
Collaborating Sponsors:
ONIRIS
Conditions:
Q Fever
Eligibility:
All Genders
18+ years
Brief Summary
Diseases naturally transmitted between animals and humans (zoonoses) are one of the leading causes of emergence or re-emergence of human infectious diseases. Non-foodborne zoonoses are commonly transm...
Detailed Description
In order to estimate seroprevalence and risk factors for Coxiella burnetii infection in humans, the investigators will conduct a cross-sectional study in three groups: * blood donors at blood donatio...
Eligibility Criteria
Inclusion
- Give a written informed consent
- Be 18 years old and over
- Be able to speak French
Exclusion
- Adults under protection (guardianship or curators)
- Contraindication for drawing blood
Key Trial Info
Start Date :
November 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
559 Patients enrolled
Trial Details
Trial ID
NCT03334019
Start Date
November 6 2017
End Date
November 1 2019
Last Update
May 30 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nantes
Nantes, France, 44093
2
CHU de Nantes
Nantes, France, 44093